CDC ApS

CVR24238016
Company financials

Key figures

Updated 8 Jun 2026
Return on assets
-20.6%
Return on equity
-20.6%
Current ratio
1,114.9%
Equity ratio
100%

Profit and loss

Reporting period
Operating profit
-1,013,200,000
Finance income
258,000
Finance expenses
966,000
Tax expense
112,000
Profit/loss for the year
-1,014,020,000

Balance sheet

Reporting period
Cash and cash equivalents
7,399,000
Current assets
7,481,000
Non-current assets
4,906,819,000
Total assets
4,914,300,000
Equity
4,913,629,000
Liabilities
671,000
Current liabilities
671,000

Working capital

Reporting period
Trade payables
344,000

Capital and dividend

Reporting period
Contributed capital
155,000
Retained earnings
3,632,001,000
Proposed dividend recognised in equity
1,281,473,000

Investments and assets

Reporting period
Long-term investments and receivables
4,906,819,000

Annual report highlights

Official annual report · 2025

Business and development

Primary activities

Main activityThe Company’s main activities are worldwide to grant and obtain loans within the group, to invest group funds, to actas holding company for investments in other group companies and to provide services to other group companies.

Management review (fallback)

Development in activities and financial circumstancesThe loss for 2025 amounted to DKK 1,014,020k after tax, which is a decrease of DKK 1,031,917k compared to 2024.

Equity for the year is positively affected by a hyperinflation adjustments in the Argentinian subsidiaries with DKK

3,594,343k.

Risks and material matters

Recognition or measurement uncertainty

Recognition and measurement in the Annual Report have not been subject to any uncertainty despite what has alreadybeen described regarding hyperinflation in accounting policies.

Significant eventsThe financial position at 31 December 2025 of the Company and the results of the activities of the Company for thefinancial year for 2025 have not been affected by any significant events.

Significant events after the reporting period

After the end of the financial year, the Company has received capital contribution of DKK 343,091,415 which consistsof an increase in share capital of DKK 300 and a share premium of DKK 343,091,115.

The Management of the Company has initiated redomiciliation to change Company registration from Denmark to theNetherlands. The redomiciliation is expected to take effect in 2026.

Significant events after the reporting period

After the end of the financial year, the Company has received capital contribution of DKK 343,091,415 whichconsists of an increase in share capital of DKK 300 and a share premium of DKK 343,091,115.

The Management of the Company has initiated redomiciliation to change Company registration from Denmark tothe Netherlands. The redomiciliation is expected to take effect in 2026.

Commitments and security

Contingent liabilities

7

Contingent liabilitiesJoint taxationThe Group’s Danish companies are jointly and severally liable for tax on the Group’s taxable income, etc.

According to the joint taxation provisions of the Danish Corporation Tax Act, the Company is therefore liable forincome taxes etc. for the jointly taxed companies and also for obligations, if any, relating to the withholding oftax on interest, royalties and dividends for these companies.

Create a free account to see up to 9 years of financial history

Create free account